{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:06:33Z","timestamp":1766268393403},"reference-count":42,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1433,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1074\/jbc.m116.734756","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T03:19:11Z","timestamp":1471058351000},"page":"21496-21509","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance"],"prefix":"10.1016","volume":"291","author":[{"given":"Ahmed M.","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.E.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Todo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.734756_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.M116.734756_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M116.734756_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.M116.734756_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01233159","article-title":"Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells","volume":"18","author":"Hayashi","year":"1992","journal-title":"Somat. Cell Mol. Genet"},{"key":"10.1074\/jbc.M116.734756_bib5","first-page":"1189","article-title":"Diminished tumorigenic phenotype after depletion of mitochondrial DNA","volume":"8","author":"Cavalli","year":"1997","journal-title":"Cell Growth Differ"},{"key":"10.1074\/jbc.M116.734756_bib6","first-page":"3889","article-title":"Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA","volume":"54","author":"Morais","year":"1994","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.734756_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","article-title":"Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA","volume":"21","author":"Tan","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.734756_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M116.734756_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.734756_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M116.734756_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.734756_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.734756_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.734756_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jb\/mvu037","article-title":"Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis","volume":"156","author":"Hoshii","year":"2014","journal-title":"J. Biochem"},{"key":"10.1074\/jbc.M116.734756_bib15","doi-asserted-by":"crossref","first-page":"22229","DOI":"10.1073\/pnas.0912074106","article-title":"Direct control of mitochondrial function by mTOR","volume":"106","author":"Ramanathan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.734756_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1\u03b1 transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.734756_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.734756_bib18","series-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"key":"10.1074\/jbc.M116.734756_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.734756_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.734756_bib21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2004.07.193","article-title":"The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas","volume":"22","author":"Chakravarti","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M116.734756_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jss.2009.06.025","article-title":"Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis","volume":"168","author":"Yang","year":"2011","journal-title":"J. Surg. Res"},{"key":"10.1074\/jbc.M116.734756_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2559.2012.04236.x","article-title":"Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas","volume":"61","author":"Korkolopoulou","year":"2012","journal-title":"Histopathology"},{"key":"10.1074\/jbc.M116.734756_bib24","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.734756_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jb\/mvt112","article-title":"Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals","volume":"155","author":"Yamada","year":"2014","journal-title":"J. Biochem"},{"key":"10.1074\/jbc.M116.734756_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Soga","year":"2003","journal-title":"J. Proteome Res"},{"key":"10.1074\/jbc.M116.734756_bib27","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M601876200","article-title":"Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption","volume":"281","author":"Soga","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.734756_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11060-014-1630-z","article-title":"Strong therapeutic potential of \u03b3-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells","volume":"121","author":"Tanaka","year":"2015","journal-title":"J. Neurooncol"},{"key":"10.1074\/jbc.M116.734756_bib29","doi-asserted-by":"crossref","first-page":"14864","DOI":"10.1074\/jbc.M510916200","article-title":"Simultaneous monitoring of ionophore- and inhibitor-mediated plasma and mitochondrial membrane potential changes in cultured neurons","volume":"281","author":"Nicholls","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.734756_bib30","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.bjp.0704823","article-title":"Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative","volume":"136","author":"Rigobello","year":"2002","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M116.734756_bib31","doi-asserted-by":"crossref","first-page":"e1930","DOI":"10.1038\/cddis.2015.263","article-title":"Early effects of the antineoplastic agent salinomycin on mitochondrial function","volume":"6","author":"Manag\u00f2","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.M116.734756_bib32","doi-asserted-by":"crossref","first-page":"32843","DOI":"10.1074\/jbc.M111.260935","article-title":"Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.734756_bib33","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.734756_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.734756_bib35","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M116.734756_bib36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.biocel.2013.06.023","article-title":"Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma","volume":"45","author":"Deng","year":"2013","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.M116.734756_bib37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1074\/jbc.M116.734756_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","article-title":"Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects","volume":"5","author":"Tuveson","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M116.734756_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.734756_bib40","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1073\/pnas.0905016106","article-title":"Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin","volume":"106","author":"Tamase","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.734756_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.stem.2009.08.018","article-title":"Autocrine TGF-\u03b2 signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors","volume":"5","author":"Ikushima","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1074\/jbc.M116.734756_bib42","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI62279","article-title":"mTORC1 is essential for leukemia propagation but not stem cell self-renewal","volume":"122","author":"Hoshii","year":"2012","journal-title":"J. Clin. Invest"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820358324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820358324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.734756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:31:34Z","timestamp":1641281494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820358324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":42,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0021925820358324"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.734756","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.734756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}